Assignee
BIOJIVA LLC
US·5 granted patents·18 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
23 records- 0189US2025223253A1Site-specific isotopic labeling of 1,4-diene systemsBIOJIVA LLC·Filed 2024·Application pending·0 cites
- 0283US12060324B2Site-specific isotopic labeling of 1,4-diene systemsBIOJIVA LLC·Filed 2022·Granted Aug 13, 2024·0 cites·16 claims
- 0382US12576059B2Methods and compositions for treatment of inflammatory diseaseBIOJIVA LLC·Filed 2024·Granted Mar 17, 2026·0 cites·6 claims
- 0481US2025325512A1Neurodegenerative Disorders And Muscle Diseases Implicating PufasBIOJIVA LLC·Filed 2025·Application pending·0 cites
- 0579US12156860B2Disorders implicating PUFA oxidationBIOJIVA LLC·Filed 2023·Granted Dec 3, 2024·0 cites·18 claims
- 0676US2025177339A1Methods for Treating TauopathyBIOJIVA LLC·Filed 2024·Application pending·0 cites
- 0775US2024238238A1Isotopically Modified Composition and Therapeutic Uses ThereofBIOJIVA LLC·Filed 2024·Application pending·0 cites
- 0874US2024091752A1Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereofBIOJIVA LLC·Filed 2023·Application pending·0 cites
- 0973US2023301956A1Methods and compositions for treatment of inflammatory diseaseBIOJIVA LLC·Filed 2022·Application pending·0 cites
- 1073US2023255917A1Methods of treating amyotrophic lateral sclerosisBIOJIVA LLC·Filed 2022·Application pending·0 cites
- 1173US2025057799A1Anti-Inflammatory Methods with Compositions Comprising Site-Specific Isotopically-Modified Fatty AcidsBIOJIVA LLC·Filed 2022·Application pending·0 cites
- 1269US11779910B2Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereofBIOJIVA LLC·Filed 2021·Granted Oct 10, 2023·0 cites·13 claims
- 1369US2023241016A1Methods for inhibiting the progression of neurodegenerative diseasesBIOJIVA LLC·Filed 2022·Application pending·0 cites
- 1468US2024091187A1Pharmaceutical compositions of d10-docosahexaenoic acid or esters thereofBIOJIVA LLC·Filed 2023·Application pending·0 cites
- 1564US2024382456A1Synergistic combination therapy for treating alsBIOJIVA LLC·Filed 2023·Application pending·0 cites
- 1664US2025248912A1Deuterated Polyunsaturated Fatty Acids Or Esters Thereof For Cosmetic ApplicationsBIOJIVA LLC·Filed 2025·Application pending·0 cites
- 1764US2025248963A1Inhibition Of Cellular Dysfunction And Cell Death With Deuterated Polyunsaturated Fatty AcidsBIOJIVA LLC·Filed 2025·Application pending·0 cites
- 1863US12109194B2Synergistic combination therapy for treating ALSBIOJIVA LLC·Filed 2022·Granted Oct 8, 2024·0 cites·18 claims
- 1961US2023333087A1Methods for monitoring patient response to treatment of retinal oxidative diseasesBIOJIVA LLC·Filed 2023·Application pending·0 cites
- 2061US2025241884A1Pharmaceutical Compositions of D10-Docosahexaenoic Acid or Esters ThereofBIOJIVA LLC·Filed 2025·Application pending·0 cites
- 2161US2023165824A1METHODS, SYSTEMS AND COMPOSITIONS FOR INHIBITION OF CELLULAR DYSFUNCTION AND CELL DEATH WITH DEUTERATED PUFAsBIOJIVA LLC·Filed 2022·Application pending·0 cites
- 2258US2025099415A1Methods for Inhibiting the Progression of Oxidative Retinal DiseaseBIOJIVA LLC·Filed 2022·Application pending·0 cites
- 2354US2025213516A1Prophylactic Methods For Treating ALSBIOJIVA LLC·Filed 2023·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →